Tokai appoints Gerald Quirk general counsel
This article was originally published in Scrip
Executive Summary
Tokai Pharmaceuticals, a biopharmaceutical company focused on developing novel therapies for prostate cancer and other hormonally-driven diseases, has named Gerald Quirk general counsel and executive vice-president of business operations. Prior to joining Tokai, Mr Quirk was a partner and co-chair of the life sciences practice at Choate, Hall & Stewart, a Boston law firm.